We are live on
!
Find out more
AIIC
AJU IB Investment Company Portfolio holdings
AUM
$30.5M
1-Year Est. Return
128.96%
This Fund
S&P 500
This Quarter
Est. Return
+4.17%
1 Year Est. Return
+128.96%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$173M
AUM Growth
-$91.7M
(-35%)
Cap. Flow
-$23.3M
Cap. Flow
% of AUM
-13.45%
Top 10 Holdings %
Top 10 Hldgs %
99.95%
Holding
11
New
–
Increased
–
Reduced
5
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Seer Inc
SEER
|
+$9.86M |
| 2 |
Atea Pharmaceuticals
AVIR
|
+$9.13M |
| 3 |
APLS
Apellis Pharmaceuticals
APLS
|
+$2.58M |
| 4 |
CLSD
Clearside Biomedical
CLSD
|
+$1.55M |
| 5 |
RAPT
RAPT Therapeutics
RAPT
|
+$210K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
LGM
OGC
AC
PL
WVP
VL
CPM
SP
AJU IB Investment Company's Q2 2021 Portfolio in Review
As of Q2 2021, AJU IB Investment Company held 11 positions worth $173M, down 35% from $265M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
AJU IB Investment Company withdrew a net $23.3M in Q2 2021, reducing 5 holdings. Its largest reduction was Seer Inc, cutting an estimated $9.86M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- AJU IB Investment Company's biggest Q2 2021 reduction was Seer Inc, cutting an estimated $9.86M.
- AJU IB Investment Company's ten largest holdings make up 100% of its $173M portfolio in Q2 2021.
- AJU IB Investment Company opened 0 new positions and closed 0 in Q2 2021.
- AJU IB Investment Company's portfolio value fell 35% quarter-over-quarter to $173M.
Based on AJU IB Investment Company's 13F filing for Q2 2021, filed 10 Aug 2021.